Cloudflare Posts Record Revenue While Cutting 20 of Workforce CEO Attributes Shift to AI US Oil Producers Ramp Up Drilling to Capitalize on Price Surge Amid Iran Conflict Chennai PortMaduravoyal Elevated Corridor Project Advances Toward November 2027 Launch Former JPMorgan Bankers Legal Counsel Withdraws Just Before Scheduled Court Hearing Markets SixWeek Record Run Top and Bottom Performers in the Club Portfolio Aluminum Prices Surge Amid Geopolitical Tensions How Major Companies Are Managing Rising Costs NP Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Gains ROP Q1 2026 Earnings Earnings Beat Driven by Strong Execution in Software and Industrial Portfolios MSGS Q1 2026 Earnings LargerThanExpected Loss as OffSeason Weighs on Results ENVB Q4 2024 Earnings EPS Misses Estimates No Revenue Reported VRNS Q1 2026 Earnings Earnings Surprise Overshadows Missing Revenue Detail IPWR Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower ONEOK Inc OKE Holds Steady Near Support Level Amid Modest Pullback HubSpot Holds Steady at 20083 Key Levels and Potential Scenarios for HUBS Siddhi Acquisition Corp SDHI Stability in SPAC Territory at 1039 KB Financial Group Inc KB Edges Higher Navigating a Tight Trading Range Gold Resource Corporation GORO Holds Steady Near Key Support as Consolidation Continues Amazons Unchallenged Western Throne Analyzing the Structural Moat in Global ECommerce OneSpan Q1 2026 Earnings EPS Beat Drives 234 Stock Gain Amid Solid Execution Tenaya Therapeutics TNYA Slips 228 as Stock Tests Key Support at 073 GD Q1 2026 Earnings Strong Earnings Beat Driven by Aerospace and Defense Momentum SKYT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges NWG Q1 2026 Earnings EPS Surpasses Estimates Despite Negative Stock Reaction CETY Q4 2024 Earnings EPS Misses Amid Sparse Disclosure Stock Declines PDS Biotechnology Q1 2026 Earnings EPS Beat and Clinical Progress Highlight PreRevenue Quarter Solidion Technology STI Q4 2025 Earnings Net Loss Widens as Stock Declines Without Revenue Disclosure Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage